{
  "description": null,
  "compose": {
    "include": [ {
      "valueSet": [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1508" ]
    } ]
  },
  "_filename": "ValueSet-2.16.840.1.113883.3.464.1003.196.12.1501.json",
  "package_name": "us.nlm.vsac",
  "date": "2018-03-10T01:00:08-05:00",
  "meta": {
    "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ],
    "versionId": "5",
    "lastUpdated": "2021-02-11T10:17:19.000-05:00"
  },
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [ {
    "coding": [ {
      "code": "US",
      "system": "urn:iso:std:iso:3166"
    } ]
  } ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for hyoscyamine.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use and prescribable hyoscyamine.),(Exclusion Criteria: Excludes concepts that represent non-prescribable, branded drugs and excludes concepts that represent components or ingredients and hyoscyamine in combination with other medications.)",
  "name": "Hyoscyamine",
  "type": null,
  "experimental": "false",
  "resourceType": "ValueSet",
  "expansion": {
    "total": 20,
    "contains": [ {
      "code": "1037234",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "benzoic acid 9 MG / hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG Oral Tablet",
      "version": "11062023"
    }, {
      "code": "1046770",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet",
      "version": "11062023"
    }, {
      "code": "1046787",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution",
      "version": "11062023"
    }, {
      "code": "1046815",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG Oral Tablet",
      "version": "11062023"
    }, {
      "code": "1046982",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.125 MG Sublingual Tablet",
      "version": "11062023"
    }, {
      "code": "1046985",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.125 MG Disintegrating Oral Tablet",
      "version": "11062023"
    }, {
      "code": "1046997",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "atropine sulfate 0.0582 MG / hyoscyamine sulfate 0.311 MG / phenobarbital 48.6 MG / scopolamine hydrobromide 0.0195 MG Extended Release Oral Tablet",
      "version": "11062023"
    }, {
      "code": "1047786",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet",
      "version": "11062023"
    }, {
      "code": "1047881",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.025 MG/ML Oral Solution",
      "version": "11062023"
    }, {
      "code": "1047895",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.125 MG/ML Oral Solution",
      "version": "11062023"
    }, {
      "code": "1047905",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.125 MG Oral Tablet",
      "version": "11062023"
    }, {
      "code": "1047916",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "1 ML hyoscyamine sulfate 0.5 MG/ML Injection",
      "version": "11062023"
    }, {
      "code": "1048124",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "12 HR atropine sulfate 0.04 MG / chlorpheniramine maleate 8 MG / hyoscyamine sulfate 0.19 MG / pseudoephedrine hydrochloride 90 MG / scopolamine hydrobromide 0.01 MG Extended Release Oral Tablet",
      "version": "11062023"
    }, {
      "code": "1048307",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule",
      "version": "11062023"
    }, {
      "code": "1048336",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 81 MG / methylene blue 10.8 MG / phenyl salicylate 32.4 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet",
      "version": "11062023"
    }, {
      "code": "1050325",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 81.6 MG / methylene blue 10.8 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet",
      "version": "11062023"
    }, {
      "code": "1087365",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral Capsule",
      "version": "11062023"
    }, {
      "code": "1440869",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet",
      "version": "11062023"
    }, {
      "code": "1807886",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "Biphasic 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet",
      "version": "11062023"
    }, {
      "code": "998726",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "hyoscyamine sulfate 0.0625 MG / phenyltoloxamine citrate 15 MG Oral Capsule",
      "version": "11062023"
    } ],
    "timestamp": "2023-11-26T21:10:50-05:00",
    "identifier": "urn:uuid:977f00f8-68dd-453d-9ebc-8d8922531051"
  },
  "title": "Hyoscyamine",
  "package_version": "0.16.0",
  "extension": [ {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString": "NCQA PHEMUR Author"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate": "2022-12-15"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate": "2021-02-11"
  } ],
  "status": "active",
  "id": "9f796795-391e-4817-a49f-61e6e3a3c7c7",
  "kind": null,
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1501",
  "identifier": [ {
    "value": "urn:oid:2.16.840.1.113883.3.464.1003.196.12.1501",
    "system": "urn:ietf:rfc:3986"
  } ],
  "version": "20180310"
}